Using chemical chaperones to increase recombinant human erythropoietin secretion in CHO cell line.


Journal

Preparative biochemistry & biotechnology
ISSN: 1532-2297
Titre abrégé: Prep Biochem Biotechnol
Pays: England
ID NLM: 9607037

Informations de publication

Date de publication:
2019
Historique:
pubmed: 17 4 2019
medline: 10 7 2019
entrez: 17 4 2019
Statut: ppublish

Résumé

In recombinant protein production, over-expressed genes induce unfolded protein response (UPR), overloaded protein aggregation in endoplasmic reticulum and its expansion. In this study, we have used 16 chemicals to improve erythropoietin production in engineered CHO cells and tried to study the mechanism of reducing protein aggregation in each treatment. Endoplasmic reticulum expansion was studied through endoplasmic reticulum specific labeling with utilizing fluorescent glibenclamide and its molecular chaperones expression were studied by real-time polymerase chain reaction. The increase in the mRNA level of EPO and endoplasmic reticulum chaperones GRP78/BiP, XBP1, ATF6, and ATF4 in different chemical treatments were not related to ER expansion. On the other hand, ER expansion in beta alanine, beta cyclodextrin and taurine treatments resulted in increased EPO secretion. Dramatically increase in EPO expression in conjugated linoleic acid, spermidine, trehalose, and maltose (19, 20, 16, and 19-fold, respectively) did not increase erythropoietin productivity, but betaine which did not caused ER expansion, with minor increase in EPO gene expression increase EPO productivity. The results indicated that betaine increase EPO secretion in engineered CHO cell line without relation to ER expansion and molecular chaperones expression.

Identifiants

pubmed: 30990119
doi: 10.1080/10826068.2018.1479865
doi:

Substances chimiques

Carbohydrates 0
EPO protein, human 0
Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
Linoleic Acids 0
Molecular Chaperones 0
Organic Chemicals 0
Recombinant Proteins 0
Erythropoietin 11096-26-7
beta-Alanine 11P2JDE17B
Cysteine K848JZ4886
Copper Sulfate LRX7AJ16DT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-544

Auteurs

Mehri Mortazavi (M)

a National Cell Bank of Iran (NCBI), Pasteur Institute of Iran , Tehran , Iran.

Mohammad Ali Shokrgozar (MA)

a National Cell Bank of Iran (NCBI), Pasteur Institute of Iran , Tehran , Iran.

Soroush Sardari (S)

b Unit of Drug Design and Bioinformatics, Department of Medical Biotechnology, Biotechnology Research Center , Pasteur Institute of Iran , Tehran , Iran.

Kayhan Azadmanesh (K)

c Department of Virology , Pasteur Institute of Iran , Tehran , Iran.

Reza Mahdian (R)

d Department of Molecular Medicine , Pasteur Institute of Iran , Tehran , Iran.

Hooman Kaghazian (H)

e Department of Recombinant Biopharmaceutical Production , Pasteur Institute of Iran , Karaj , Iran.

Seyed Nezamedin Hosseini (SN)

f Department of Production and Research , Pasteur Institute of Iran , Karaj , Iran.

Mohammad Hossein Hedayati (MH)

g Department of Quality Control , Production and Research Complex, Pasteur Institute of Iran , Tehran , Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH